Fuse Medical, Inc. appointed Mark W. Brooks, the company's Chairman of the Board, to the position of President. The board appointed Christopher C. Reeg, the company's Chief Executive Officer and a member of the Board, to the position of Secretary. The Board appointed William E. McLaughlin, III, the company's Interim Chief Financial Officer and a member of the Board, to the position of Chief Financial Officer and Treasurer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 USD | -13.63% | -.--% | -28.61% |
2023 | Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M | MT |
2023 | Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.61% | 5.77M | |
-6.03% | 180B | |
+1.08% | 109B | |
-2.19% | 68.93B | |
-5.98% | 46.41B | |
+12.31% | 45.43B | |
+7.38% | 43.26B | |
+15.98% | 30.05B | |
+16.10% | 25.19B | |
-9.57% | 23.19B |
- Stock Market
- Equities
- FZMD Stock
- News Fuse Medical, Inc.
- Fuse Medical, Inc. Announces Management Changes